Skanska has finalized a contract with Seagen to construct a 25,000 square meter biomanufacturing facility for the global biotechnology company. The facility will include manufacturing, storage, shipping, office, and café space in Everett, Washington, USA. The contract is worth USD 215 M, about SEK 2.25 billion, which will be included in the U.S. order bookings for the third quarter, 2023.
Seagen announced their plans to build the project in April 2022. Construction is underway and completion is anticipated for Q4, 2024.
PRNewswire
previous
TIER IV joins World Economic Forum's Unicorn Community: Leading global innovation through open source
next
